WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-06-03726$1.72
$1.25kSell
Amy ParisonSVP Chief Financial Officer2025-06-03446$1.72
$768.90Sell
Gilmore Neil OneillCEO2025-06-0315,192$1.72
$26.19kSell
Gilmore Neil OneillCEO2025-03-0416,632$1.71
$28.46kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-03-042,891$1.71
$4.95kSell
Erick LuceraEVP CHIEF FINANCIAL OFFICER2025-03-044,109$1.71
$7.03kSell
Baisong MeiEVP CHIEF MEDICAL OFFICER2024-12-03541$2.08
$1.12kSell
Gilmore Neil OneillCEO2024-12-031,618$2.08
$3.36kSell
Baisong MeiEVP CHIEF MEDICAL OFFICER2024-09-04518$3.43
$1.77kSell
Gilmore Neil OneillCEO2024-09-041,555$3.43
$5.33kSell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.92%7,466,254$23.00MInstitution
Blackrock Inc7.99%6,690,680$20.61MInstitution
Third Rock Ventures III LP4.67%3,906,176$12.03MInsider
Kevin P. Starr4.67%3,906,176$12.03MInsider
Polaris Venture Management Co VI LLC4.54%3,797,144$11.70MInsider
Viking Global Investors LP3.58%2,996,590$9.23MInsider
Kevin Bitterman3.34%2,797,144$8.62MInsider
Flagship Ventures Fund IV LP3.33%2,786,967$8.58MInsider
Boris Nikolic3.21%2,684,572$8.27MInsider
Morgan Stanley3.18%2,658,921$8.19MInstitution

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT52.57%39.39%Net SellingNet Selling
TRDA46.77%53.23%Net SellingNet Selling
CDXS46.10%53.90%Net BuyingNet Buying
PRQR38.34%0.00%
OABI51.80%26.47%Net BuyingNet Buying
View Top Biotech Stocks

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 52.57% institutional shareholders, 39.39% Editas Medicine insiders, and 8.04% retail investors. Third Rock Ventures III LP is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 4.67% of the company. Third Rock Ventures III LP's Editas Medicine shares are currently valued at $11.95M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.